Adcendo

Series-B+
adcendo.com Biotech & Healthcare Founded 2017
Total Funding $75M
Latest Round $75M Series-B+
Last Announced Apr 14, 2026
Investors Undisclosed
Decision Makers 6 Verified

About Adcendo

At Adcendo, we are developing a new generation of antibody-drug conjugates (ADCs) engineered to address cancers with high unmet medical need.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Year Founded 2017
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website adcendo.com
Domain Registered Date Jul 22, 2018

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $75,000,000 · Series-B+

    fundraisingfox.com

  2. Milestone

    Website domain registered

    adcendo.com

  3. Milestone

    Company founded

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Adcendo.

Funding History

1 Round
Series-B+ · Apr 14, 2026

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts